Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in human benign and malignant thyroid lesions

Medical Science Monitor

Volumn 18, Issue 4, 2012, Pages

  Giaginis, Constantinos ^a   Demetriou, Nikoleta ^a,b   Alexandrou, Paraskevi ^b   Stolakis, Vasileios ^a   Delladetsima, Ioanna ^b   Klijanienko, Jerzy ^c   Griniatsos, Ioannis ^b   Theocharis, Stamatios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c INSTITUT CURIE   (France)

Author keywords

Biomarker; Clinic opathological parameters; Diagnosis; Immunohisto chemistry; RCAS1; Thyroid malignancy

Indexed keywords

RCAS1 ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; THYROID CANCER; THYROID HYPERPLASIA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; TUMOR VOLUME;

EID: 84859538643     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882613     Document Type: Article

References (34)

1. Sonoda K, Nakashima M, Kaku T et al: A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer, 1996; 77: 1501-9
2. Yamaguchi K, Enjoji M, Nakashima M et al: Novel serum tumor marker, RCAS1, in pancreatic diseases. World J Gastroenterol, 2005; 11: 5199-202
3. Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med, 1999; 5: 938-42
4. Matsushima T, Nakashima M, Oshima K et al: Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood, 2001; 98: 313-21
5. Sonoda K, Miyamoto S, Hirakawa T et al: Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer. Gynecol Oncol, 2005; 97: 772-79
6. Sonoda K, Miyamoto S, Nakashima M, Wake N: The biological role of the unique molecule RCAS1: a bioactive marker that induces connective tissue remodeling and lymphocyte apoptosis. Front Biosci, 2008; 13: 1106-16
7. Giaginis C, Giagini A, Theocharis S: Receptor-binding Cancer Antigen expressed on SiSo cells (RCAS1): a novel biomarker in the diagnosis and prognosis of human neoplasia. Histol Histopathol, 2009; 24: 761-76
8. Leenhardt L, Grosclaude P, Cherie-Challine L: Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid, 2004; 14: 1056-60
9. Jemal A, Siegel R, Ward E et al: Cancer statistics, 2009. CA Cancer J Clin, 2009; 59: 225-49
10. Davies L, Welch HG: Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA, 2006; 295: 2164-67
11. Ward EM, Jemal A, Chen A: Increasing incidence of thyroid cancer: is diagnostic scrutiny the sole explanation? Future Oncol, 2010; 6: 185-88
12. Gharib H, Papini E: Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am, 2007; 36: 707-35
13. Stang MT, Carty SE: Recent developments in predicting thyroid malignancy. Curr Opin Oncol, 2009; 21: 11-17
14. Fischer S, Asa L: Application of immunohistochemistry to thyroid neoplasms. Arch Pathol Lab Med, 2008; 132: 359-72
15. Vriens MR, Schreinemakers JM, Suh I et al: Diagnostic markers and prognostic factors in thyroid cancer. Future Oncol, 2009; 5: 1283-93
16. Besic N, Sesek M, Peric B et al: Predictive factors of carcinoma in 327 patients with follicular neoplasm of the thyroid. Med Sci Monit, 2008; 14(9): CR459-67
17. Golbidi S, Laher I: Antioxidant therapy in human endocrine disorders. Med Sci Monit, 2010; 16(1): RA9-24
18. Fukuda M, Tanaka A, Hamao A et al: Expression of RCAS1 and its function in human squamous cell carcinoma of the oral cavity. Oncol Rep, 2004; 12: 259-67
19. Toyoshima T, Nakamura S, Kumamaru W et al: Expression of tumor-associated antigen RCAS1 and its possible involvement in immune evasion in oral squamous cell carcinoma. J Oral Pathol Med, 2006; 35: 361-68
20. Tsai TC, Yu CH, Cheng SJ et al: Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. Oral Oncol, 2008; 44: 759-66
21. Nakakubo Y, Hida Y, Miyamoto M et al: The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus. Cancer Lett, 2002; 177: 101-5
22. Ikeguchi M, Ohoro S, Maeda Y et al: Protein and gene expression of tumor-associated antigen RCAS1 in esophageal squamous cell carcinoma. Oncol Rep, 2003; 10: 1891-94
23. Kato H, Nakajima M, Masuda N et al: Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis. J Surg Oncol, 2005; 90: 89-94
24. Tsujitani S, Saito H, Oka S et al: Prognostic significance of RCAS1 expression in relation to the infiltration of dendritic cells and lymphocytes in patients with esophageal carcinoma. Dig Dis Sci, 2007; 52: 549-54
25. Ito Y, Yoshida H, Nakano K et al: Overexpression of human tumor-associated antigen, RCAS1, is significantly linked to dedifferentiation of thyroid carcinoma. Oncology, 2003; 64: 83-89
26. th ed. London: Mosby, 2004; 2809-10
27. Giaginis C, Davides D, Zarros A et al: Clinical significance of tumor-associated antigen RCAS1 expression in human pancreatic ductal adenocarcinoma. Dig Dis Sci, 2008; 53: 1728-34
28. Giaginis C, Zarros A, Alexandrou P et al: Evaluation of coxsackievirus and adenovirus receptor expression in human benign and malignant thyroid lesions. APMIS, 2010; 118: 210-21
29. Giaginis C, Michailidi C, Stolakis V et al: Expression of DNA repair proteins, MSH2, MLH1 and MGMT in human benign and malignant thyroid lesions: an immunohistochemical study. Med Sci Monit, 2011; 17(3): BR81-90
30. Arif S, Blanes A, Diaz-Cano SJ: Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma. Histopathology, 2002; 41: 357-62
31. Akashi T, Oimomi H, Nishiyama K et al: Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer. Pancreas, 2003; 26: 49-55
32. Sonoda K, Miyamoto S, Nakashima M, Wake N. Receptor-binding cancer antigen expressed on SiSo cells induces apoptosis via ectodomain shedding. Exp Cell Res, 2010; 316: 1795-803
33. Engelsberg A, Hermosilla R, Karsten U et al: The Golgi protein RCAS1 controls cell surface expression of tumor-associated O-linked glycan antigens. J Biol Chem, 2003; 278: 22998-3007
34. Giaginis C, Margeli A, Kouraklis G et al: Diagnostic and prognostic utility of serum Receptor-binding Cancer Antigen expressed on SiSo cells (RCAS1) levels in colon cancer patients. Int J Biol Markers, 2009; 24: 70-76